Clinical use of targeted high-throughput whole-genome sequencing for a dengue virus variant

Articles in the same Issue

1. Frontmatter
2. Editorial
3. Mass spectrometry or immunoassay: est modus in rebus
4. Reviews
5. The use of liquid chromatography-tandem mass spectrometry for therapeutic drug monitoring of antibiotics in cancer patients
6. Tackling serum folate test in European countries within the health technology assessment paradigm: request appropriateness, assays and health outcomes
7. Genetics and Molecular Diagnostics
8. Genetic diagnosis of α₁-antitrypsin deficiency using DNA from buccal swab and serum samples
9. General Clinical Chemistry and Laboratory Medicine
10. Serum triglyceride measurements: the commutability of reference materials and the accuracy of results
11. Variant peptide detection utilizing mass spectrometry: laying the foundations for proteogenomic identification and validation
12. Evaluation of two fully automated immunoassay based tests for the measurement of 1α,25-dihydroxyvitamin D in human serum and comparison with LC-MS/MS
13. Parallel diurnal fluctuation of testosterone, androstenedione, dehydroepiandrosterone and 17OHprogesterone as assessed in serum and saliva: validation of a novel liquid chromatography-tandem mass spectrometry method for salivary steroid profiling
14. Determination of oxycodone and its major metabolites noroxycodone and oxymorphone by ultra-high-performance liquid chromatography tandem mass spectrometry in plasma and urine: application to real cases
15. Identification and quantitation of phosphatidylethanols in oral fluid by liquid chromatography-tandem mass spectrometry
16. Relationship between plasma and salivary melatonin and cortisol investigated by LC-MS/MS
17. Paramagnetic micro-particles as a tool for rapid quantification of apixaban, dabigatran, edoxaban and rivaroxaban in human plasma by UHPLC-MS/MS
18. Measurements of serum non-ceruloplasmin copper by a direct fluorescent method specific to Cu(II)
19. The serum concentrations of leptin and MCP-1 independently predict low back pain duration
20. Immunoassay screening in urine for synthetic cannabinoids – an evaluation of the diagnostic efficiency
21. Cancer Diagnostics
22. Study of kallikrein-related peptidase 6 (KLK6) and its complex with α₁-antitrypsin in biological fluids
23. Cardiovascular Diseases
24. A candidate liquid chromatography mass spectrometry reference method for the quantification of the cardiac marker 1-32 B-type natriuretic peptide
25. The natriuretic peptide MR-proANP predicts all-cause mortality and adverse outcome in community patients: a 10-year follow-up study
26. CASZ1 loss-of-function mutation contributes to familial dilated cardiomyopathy
27. Diabetes
28. Evaluating new HbA_1c methods for adoption by the IFCC and NGSP reference networks using international quality targets
29. Infectious Diseases
30. Analytical and diagnostic performance of two automated fecal calprotectin immunoassays for detection of inflammatory bowel disease
31. Letters to the Editor
32. Is fasting necessary for lipid profile determinations? Some considerations from the perspective of the clinical laboratory
33. Precision of nonfasting lipid profiles should focus on clinical relevance rather than necessarily obtaining the least variation
34. Triglyceride concentrations should be measured after elimination of free glycerol to exclude interindividual variations due to adiposity and fasting status
35. Estimation of the reference interval for serum folate measured with assays traceable to the WHO International Standard
36. Implausible elevation of peripheral thyroid hormones during therapy with a protein supplement
37. Interference in Na⁺ measurements on the Siemens RAPIDPoint^® 500 after nortriptyline intoxication: a case report
38. Usefulness of maternal red cell antibodies to predict hemolytic disease of the fetus and newborn and significant neonatal hyperbilirubinemia: a retrospective study
39. Improvement of the Sandell-Kolthoff reaction method (ammonium persulfate digestion) for the determination of iodine in urine samples
40. Clinical use of targeted high-throughput whole-genome sequencing for a dengue virus variant